beta

AEMD

Aethlon Medical Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Aethlon is focused on addressing unmet needs in global health. The Aethlon Hemopurifier is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. In cancer, the Hemopurifier is designed to deplete the presence of circulating tumor-derived exosomes that promote immune suppression.

Market Cap: 32.6 Million

Primary Exchange: NASDAQ

Website: www.aethlonmedical.com

Shares Outstanding: 15.4 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.0958078695422487

Sector: Manufacturing

Industry: Analytical Laboratory Instrument Manufacturing

Ethical Flags

Longest drawdown: 2418 trading days

From: 2014-11-24 To: 2021-12-03

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-04-14 50.0 1.0 50.0
Data provided by IEX Cloud